TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Area Under the Concentration versus time curve (AUC) of HRS953
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Concentration (Cmax) of HRS9531
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ratio of bioavailability between new and original formulation of HRS9531
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Everyday Cognition 2 (ECog2)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Percentage of patients achieving BP goal (MAP ≥65 mmHg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Sensitivity and specificity of RETINA-AI Galaxy v2.0
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: care burden
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Breast lymph node metastasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: No lymph node metastasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: flare prevention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence rate of neck
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Any psychiatric disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Any psychotropic medication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical performance change in physician behavior
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Impact on physician confidence in clinical care decision-making
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Optical characterization accuracy of colorectal polyps
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Burning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Tolerability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PrEP continuation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Cases of nosocomial influenza
Endpoint domain: Adverse events/effects
Primary endpoint: Concordance between non-invasive Hgb and serum Hgb
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient satisfaction with non-invasive Hgb
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Nurse satisfaction with non-invasive Hgb
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Hematic oxidative stress measured by ROS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hematic oxidative stress measured by biological antioxidant potential
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: State Mindfulness Scale for Physical Activity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Behavioral Regulations in Exercise Scale-2
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Quality of Life - EORTC-BR23
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Extension knee range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disease remission rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Antidepressant Efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Beck Depression Inventory-II (BDI-11)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Short form-12 items health survey (SF-12)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quality of life/emotional well-being
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Hip girth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in post-operative anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sensitivity of automatic identification of co-prescription at Risk of Drug Interactions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of reduction in the peritoneal carcinomatosis index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: number of subjects achieving HbA1c <6.5% at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of subjects failing to achieving HbA1c <6.5% Long-term
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of Adherence
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Neck Pain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: severity of vomiting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of modifiable intraoperative CAL risk factors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Non inferiority of sacro-spinous fixation compared to sacrocolpopexy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Systemic Blood Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Neurodevelopmental Outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction assessed by questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Satisfaction assessed by interview
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Feasibility assessed by questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feasibility assessed by interview
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Use of antimicrobial
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Amount of dental substance loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: the detection and negotiation of canals
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: the treatment duration
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: LVOT VTI variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: sensitivity of the fecal immunochemical test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Complete Spontaneous Bowel Movements (CSBM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Development of receptive language
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Updating speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Updating accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in weight from baseline to the end of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Plasma concentration of Remimazolam
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in anti-SARS-CoV-2 IgG titer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of participants who achieve high-positive antibody titer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Effectiveness of online teaching
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Reduction of children's exposure to emotional and physical violence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduction of parents' or teachers' use of emotional and physical violence
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients with newly diagnosed ischemic stroke
Endpoint domain: Mortality/survival
Primary endpoint: Edinburgh Depression Scale Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in voice
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difficulty swallowing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uptake of [89Zr]Df-IAB22M2C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: All-Cause Mortality at 28 days
Endpoint domain: Mortality/survival
Primary endpoint: Death Due to Respiratory Failure
Endpoint domain: Mortality/survival
Primary endpoint: steroids sparing effect of the drug
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: severity and complications of the uveitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of tissue expression of OPA1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of tissue expression of MFN1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of tissue expression of MFN2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of tissue expression of Fis1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of tissue expression of Drp1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of tissue expression of Nfr1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Pain on the Visual Analog Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical activity measured by Fitbit (steps)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of time spent sedentary based on activity counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of corneal endothelium cell density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with intracranial vessel perforation and/or dissection
Endpoint domain: Adverse events/effects
Primary endpoint: Event rate of Major Congenital Malformations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change of cognitive flexibility
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change of inhibition
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Presence of free fluid (blood) in the pacemaker pocket
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Injury during diving practice
Endpoint domain: Adverse events/effects
Primary endpoint: Impact of subject-reported ISRs on ADL
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Age of first criminal behavior
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: P/E2 ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: ECG R-R interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: ECG QRS-complex duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: ECG QTc interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Tumor detection rate in the positive screening results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: State-Trait Anxiety Inventory - State
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement in lumbar pain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in mean itch NRS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with Clostridium difficile infection
Endpoint domain: Adverse events/effects
Primary endpoint: GOHAI score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Geometric mean concentrations of mumps antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Fraction of exhaled nitric oxide (FeNO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Exercise attendance rate
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Exercise compliance rate
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: interleukin 1 plasma concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: interleukin 6 plasma concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: intraabdominal pressure per mmHg
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary incontinence assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intensity of pain on admission or in the first 24 hours after surgery or at the start of care
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exclusive breastfeeding at 6 months
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pain Threshold Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Life-Space Assessment (LSA)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Falls Efficacy Scale International (FES-I)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of mortality post-operative
Endpoint domain: Mortality/survival
Primary endpoint: The incidence of recurrent endocarditis
Endpoint domain: Adverse events/effects
Primary endpoint: 90-day mortality Rate
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of postprandial capillary glucose values above target
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of puncture attempts in case of successful LP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of metabolic liver diseases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Condition improvement in oral cGVHD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of secondary procedures
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Children's autonomy at school
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Children's social participation in leisure activities
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Families' social participation
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Cognitive functioning assessed through Mini-Mental State Examination (MMSE)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in cognitive functioning assessed through Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-COG)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in memory function evaluated through Memory Alteration Test (MAT)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Spinal Cord Independence Measure (SCIM) vIII
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Intracranial progression-free survival (IPFS)
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of Acute graft versus host disease
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants Achieving Serum Uric Acid Level <=6.0 mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Willingness regarding hematopoietic stem cell transplantation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: CDAI (Clinical Disease Activity Index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dose limiting pulmonary and esophageal toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Total amount of tramadol use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: degree of hepatic fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Maximum Deadlift weight lifted
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived spine vulnerability questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fibrosis-4 (FIB-4) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AST to Platelet Ratio Index (APRI) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum transforming growth factor - beta 1 (TGF- β1) level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognition Improvement
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Fugal Myer assessment scale (FMAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants reporting local reactions within 7 days after vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants reporting systemic events within 7 days after vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Back Squat Velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Back Squat Power Output
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived Effort of Back Squat
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Muscle Activation during Back Squat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recurrence of pulsatile tinnitus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Arterial Pressure (MAP) LLA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Isometric hip adductor and abductor strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Hop test function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Slow wave activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Gambling-related cognitions scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: AUC of the ROC analysis to diagnose asthma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood eosinophil count: ROC analysis AUC to diagnose asthma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Combination of FeNO + Blood eosinophil count: ROC analysis AUC to diagnose asthma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Water volume displacement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Edema Symptom Diary score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Rate of patients with endometriosis non-responsive to medical treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic accuracy for isoniazid (INH), rifampicin (RIF), fluoroquinolone (FQ) and aminoglycoside (AMG) resistance detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glucose levels monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Humanin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Prevalence and incidence of mild cognitive impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence and incidence of dementia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Conversion rate of normal to mild cognitive impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Conversion rate of mild cognitive impairment to dementia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence and incidence of movement disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of opioids needed by patients
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Time to the first analgesic rescue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of nab-sirolimus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients who did not progress
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Total rescue morphine consumption
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rotational (mal)alignment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SICI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: ICF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: LICI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes